Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1987 3
1988 1
2001 1
2007 1
2008 2
2011 2
2012 2
2013 1
2014 3
2015 1
2017 2
2018 3
2019 3
2020 6
2021 11
2022 8
2023 10
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas.
Heinze K, Cairns ES, Thornton S, Harris B, Milne K, Grube M, Meyer C, Karnezis AN, Fereday S, Garsed DW, Leung SCY, Chiu DS, Moubarak M, Harter P, Heitz F, McAlpine JN, DeFazio A, Bowtell DDL, Goode EL, Pike M, Ramus SJ, Pearce CL, Staebler A, Köbel M, Kommoss S, Talhouk A, Nelson BH, Anglesio MS. Heinze K, et al. Among authors: moubarak m. Clin Cancer Res. 2023 Sep 1;29(17):3471-3483. doi: 10.1158/1078-0432.CCR-22-3815. Clin Cancer Res. 2023. PMID: 37339172 Free PMC article.
Overcoming Drug Resistance in Advanced Prostate Cancer by Drug Repurposing.
Bahmad HF, Demus T, Moubarak MM, Daher D, Alvarez Moreno JC, Polit F, Lopez O, Merhe A, Abou-Kheir W, Nieder AM, Poppiti R, Omarzai Y. Bahmad HF, et al. Among authors: moubarak mm. Med Sci (Basel). 2022 Feb 18;10(1):15. doi: 10.3390/medsci10010015. Med Sci (Basel). 2022. PMID: 35225948 Free PMC article. Review.
PARP inhibitors (PARPi) prolongation after local therapy for oligo-metastatic progression in relapsed ovarian cancer patients.
Gauduchon T, Kfoury M, Lorusso D, Floquet A, Ventriglia J, Salaun H, Moubarak M, Rivoirard R, Polastro L, Favier L, You B, Berton D, de la Motte Rouge T, Mansi L, Abdeddaim C, Prulhiere K, Lancry Lecomte L, Provansal M, Dalban C, Ray-Coquard I. Gauduchon T, et al. Among authors: moubarak m. Gynecol Oncol. 2023 Jun;173:98-105. doi: 10.1016/j.ygyno.2023.04.002. Epub 2023 Apr 25. Gynecol Oncol. 2023. PMID: 37105063
Long term follow-up after minimally invasive sacrocolpopexy.
Khalil N, Moubarak M, Alkassis M, Kassis N, Moukarzel M, Atallah D. Khalil N, et al. Among authors: moubarak m. Int Urogynecol J. 2023 Jun;34(6):1279-1283. doi: 10.1007/s00192-022-05430-z. Epub 2022 Dec 28. Int Urogynecol J. 2023. PMID: 36576540
The Use of Stem Cell-Derived Organoids in Disease Modeling: An Update.
Azar J, Bahmad HF, Daher D, Moubarak MM, Hadadeh O, Monzer A, Al Bitar S, Jamal M, Al-Sayegh M, Abou-Kheir W. Azar J, et al. Among authors: moubarak mm. Int J Mol Sci. 2021 Jul 17;22(14):7667. doi: 10.3390/ijms22147667. Int J Mol Sci. 2021. PMID: 34299287 Free PMC article. Review.
Favipiravir in SARS-CoV-2 Infection: Is it Worth it?
Batiha GE, Moubarak M, Shaheen HM, Zakariya AM, Usman IM, Rauf A, Adhikari A, Dey A, Alexiou A, Hetta HF, Al-Gareeb AI, Al-Kuraishy HM. Batiha GE, et al. Among authors: moubarak m. Comb Chem High Throughput Screen. 2022;25(14):2413-2428. doi: 10.2174/1386207325666220414111840. Comb Chem High Throughput Screen. 2022. PMID: 35430987
The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections.
Moubarak M, Kasozi KI, Hetta HF, Shaheen HM, Rauf A, Al-Kuraishy HM, Qusti S, Alshammari EM, Ayikobua ET, Ssempijja F, Afodun AM, Kenganzi R, Usman IM, Ochieng JJ, Osuwat LO, Matama K, Al-Gareeb AI, Kairania E, Musenero M, Welburn SC, Batiha GE. Moubarak M, et al. Life (Basel). 2021 Jul 23;11(8):734. doi: 10.3390/life11080734. Life (Basel). 2021. PMID: 34440478 Free PMC article. Review.
57 results